Pediatric Infectious Diseases: Open Access

A novel treatment for a Han patient with high risk of coronary obstruction underwent TAVI procedure using a novel second- generation device

In this study the obstruction of coronary ostium (CO) is unusual but lethal complication under TAVI procedure it is not normally accepted that a range distance between the coronary ostium (CO) and the annulus lower than 10mm or in case of sinus of Valsalva diameter around 30mm, while the existing of bulky counted as a leaflet, this is also in case of the valve in valve implantation, in this situation consider as a risks for coronary occlusion (CO) as for TAVI methodology (1-2). In TAVAI device using J-Valve™ system is a brand new second-generation and TAVI device divided in to three U-shapes anatomically oriented devices such as “claspers” which could favour conjectural and “selfpositioning” valve implantation (3). Furthermore, Due to the ability to enclosure and snaffle the main Major of leaflets in main time of valve implantation and in specific designed extra bear area located on the valve stent. The novelty of this valve is particular appropriate for the patient who is more in the risk for coronary ostium (CO) such as valve-invalve implantation. In this study convey the patient of utilize J-Valve in therapy the case with an high risk of coronary ostium (CO) during TAVI procedure.

Author(s): Duraid Al-Midfai

Abstract | Full-Text | PDF

Share this